Filing Details

Accession Number:
0001493152-22-023376
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 20:17:12
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 20:17:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX In Vitro & In Vivo Diagnostic Substances (2835) 271041563
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1806505 L. Jennifer Carter C/O Oncocyte Corporation
15 Cushing
Irvine CA 92618
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2022-08-15 10,000 $0.00 20,000 No 4 A Direct
Common Stock, No Par Value Acquisiton 2022-08-16 10,500 $0.95 30,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Acquisiton 2022-08-15 45,000 $0.00 45,000 $0.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,000 2032-08-15 No 4 A Direct
Footnotes
  1. The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
  2. Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.